Riskpilot← Back to searchSign inGet full accessMatrecept Sweden AB
ABActiveOrg 5592358096Skönningared 297Other non-specialised retail sale · NACE 4712Est. 20200 employees
Revenue 2025
SEK 102K
EBITDA margin
24.9%
+1128% vs 2024
Equity ratio
46.6%
Financial strength
Net profit 2025
SEK 26K
+1204% vs 2024
| Revenue | SEK 102K | — |
| EBITDA | SEK 25K | +1128% |
| Net profit | SEK 26K | +1204% |
| Total assets | SEK 106K | +268% |
| Equity | SEK 49K | +108% |
| Employees | 0 | — |
Legal name
Matrecept Sweden AB
Org number
5592358096
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
8 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva e-handel, bloggportal, postorderhandel och detaljhandel på internet med brett sortiment inom matindustrin samt därmed förenlig verksamhet.
Address
Skönningared 297
Email
adde_2010@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 132 | 60 | 0 | — | 102 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 28 | −17 | −8 | −2 | 25 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 28 | −17 | −8 | −2 | 25 |
| Net financials | — | −2 | −8 | 0 | 0 |
| Profit before tax | 28 | −19 | −17 | −2 | 26 |
| Tax | −6 | — | — | — | — |
| Net profit | 22 | −19 | −17 | −2 | 26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 94 | 45 | 31 | 29 | 106 |
| Equity | 47 | 28 | 26 | 24 | 49 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 48 | 17 | 5 | 5 | 56 |
| Total debt | 48 | 17 | 5 | 5 | 56 |
EBITDA margin
24.9%
This company
15.8%
Market median
+58% vs market
20212025
Equity ratio
46.6%
This company
38.2%
Market median
+22% vs market
20212025
Return on equity
51.8%
This company
18.4%
Market median
+182% vs market
20212025
Net profit margin
25.1%
This company
8.1%
Market median
+210% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-01-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Matrecept Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Gabriel Jonsson | Deputy Board Member | 0 companies |
| Andreas Erik Gunnar Klintbom | Board of Directors | 0 companies |
| Felix Erik Sandberg | Board of Directors | 0 companies |
| Thor Arne Gotthold Wallin | Board of Directors | 0 companies |